Russia’s Coronavirus Vaccine Offers 92% Protection Against the Infection

Sputnik V, Russia’s vaccine for Coronavirus, offers 92% protection against the disease, Russian Direct Investment Fund (RDIF) has confirmed while disclosing the initial results of phase-III clinical trials of the drug.

Gamaleya Institute, the maker of Sputnik V, is currently holding the phase-III human trials in 29 clinics across Moscow which involves 40,000 volunteers. The preliminary results are based on data of 16,000 trial participants who had already received the Sputnik V vaccine, RDIF said in a statement.


ALSO READ

Pfizer’s COVID-19 Vaccine Offers 90% Protection Against the Virus


Kirill Dmitriev, CEO of RFID, has said that “we are showing, based on the data, that we have a very effective vaccine, adding that it is the sort of news that the vaccine’s developers will talk about one day with their grandchildren.”

Earlier in August, Russian President Vladimir Putin revealed that Russia had registered the world’s first effective Coronavirus vaccine named ‘Sputnik V.’


ALSO READ

Dr. Atta ur Rehman Claims Pfizer’s COVID-19 Vaccine Not Suitable for Pakistanis


Russia’s announcement comes days after Pfizer and BioNTech, the US and German vaccine makers, claimed that their COVID-19 vaccine offers 90% protection against the disease without any side effects.

Pfizer and BioNTech had tested the vaccine on 43,500 participants in phase-III clinical trials that were held across 6 countries.



Get Alerts

Follow ProPakistani to get latest news and updates.


ProPakistani Community

Join the groups below to get latest news and updates.



>